The West Virginia Racing Commission (WVRC) in late summer or early fall plans to hold a fact-finding meeting on use of race-day furosemide day, officials said Aug. 4.

The meeting will be similar to one held in Kentucky last fall. The Kentucky Horse Racing Commission (KHRC) took testimony on the pros and cons of furosemide, an anti-bleeding medication known Salix or Lasix designed to prevent or lessen the effects of exercise-induced pulmonary hemorrhage.

The KHRC this year passed regulations that would phase out race-day Salix in graded and listed states effective Jan. 2, 2014. The regulation, however, must first be approved by the General Assembly.

Racing regulations in West Virginia also must be approved by the state legislature. The deadline for submitting regulations for review is Aug. 31, meaning there’s no time to address Salix for 2013

Create a free account with TheHorse.com to view this content.

TheHorse.com is home to thousands of free articles about horse health care. In order to access some of our exclusive free content, you must be signed into TheHorse.com.

Start your free account today!

Already have an account?
and continue reading.